Hailey Biotech announced that the company's board of directors received a written resignation report from Deputy General Manager Liu Yanlin on December 2, 2024. Due to the company's business adjustments, Liu Yanlin's work was adjusted accordingly and applied to resign as the company's deputy general manager. According to relevant regulations, Liu Yanlin's resignation report takes effect from the date it is submitted to the board of directors. Liu Yanlin will no longer hold any position in the company after the handover of related work is completed. As of the disclosure date of the announcement, Liu Yanlin held 1 million shares of restricted shares granted by the company but not yet lifted, and 1.7 million shares of stock options granted but not yet exercised.